Description:
DESCRIPTION:
Droncit® Feline Cestocide Tablets
are sized for easy oral administration to either adult cats or kittens. The
tablets may be crumbled and mixed with the feed.
INDICATIONS:
Droncit® Feline Cestocide Tablets
are indicated for the removal of the following feline cestodes: Dipylidium
caninum and Taenia taeniaeformis
ACTION:
Droncit® (praziquantel) is absorbed,
metabolized in the liver and excreted in the bile. Upon entering the digestive
tract from the bile, cestocidal activity is exhibited.1
Following exposure to praziquantel, the tapeworm loses its ability to resist
digestion by the mammalian host. Because of this, whole tapeworms, including the
scolex, are very rarely passed after administration of praziquantel. In many
instances only disintegrated and partially digested pieces of tapeworms will be
seen in the stool. The majority of tapeworms killed are digested and are not
found in the feces.
USE DIRECTIONS:
Droncit® Feline Cestocide Tablets
may be administered directly per os or crumbled and mixed with the feed. The
recommended dosage of praziquantel varies according to body weight. Smaller
animals require a relatively larger dosage because of their higher metabolic
rate. The optimum dose for each individual animal will be achieved by utilizing
the following dosage schedule:
Cats and Kittens*
|
4 lbs. & under
|
½ tablet
|
|
5-11 lbs.
|
1 tablet
|
|
Over 11 lbs.
|
1½ tablets
|
*Not intended for use in kittens less than 6
weeks of age.
FASTING:
The recommended dosage of
praziquantel is not affected by the presence or absence of food in the
gastrointestinal tract, therefore, FASTING IS NEITHER NECESSARY NOR RECOMMENDED.
RETREATMENT: For those animals maintained on premises where reinfections are
likely to occur, clients should be instructed in the steps necessary to prevent
reinfection; otherwise, retreatment may be necessary. This is especially true in
cases of Dipylidium caninum infections where reinfection is almost certain to
occur if fleas are not removed from the animal and its environment.
OVERDOSAGE:
The safety index has been derived
from controlled safety evaluations, clinical trials and prior approved use in
foreign countries. Dosages of 5 times the labeled rate at 14 day intervals to
cats as young as 5½ weeks did not produce clinical signs of toxicity. No
significant clinical chemistry, hematological, or Histopathological changes
occurred. Symptoms of gross overdosage include vomiting, salivation, diarrhea
and depression.
CONTRAINDICATIONS:
There are no known contraindications to
the use of praziquantel in cats.
PREGNANCY:
Droncit® (praziquantel) has been
tested in breeding and pregnant cats. No adverse effects were noted.
ADVERSE REACTIONS:
One instance of diarrhea and one of
salivation (1.5%) were reported during the field trials in which 135 cats were
administered Droncit® Feline Cestocide.
WARNING:
Keep out of the reach of
children. Not for human use.
SOLD TO VETERINARIANS ONLY
CAUTION:
Federal (U.S.A.) Law restricts this drug to
use by or on the order of a licensed veterinarian.
|